ARO80 Antibody

What is ARO80 and why is it important in yeast research?

ARO80 is a zinc cluster transcriptional activator protein found exclusively in fungi, particularly in Saccharomyces species. It plays a critical role in regulating the catabolism of aromatic amino acids through the Ehrlich pathway by controlling the expression of key genes, particularly ARO9 and ARO10 . Its importance in research stems from its direct influence on the production of valuable aromatic compounds like phenylethanol (PE) and phenylethyl acetate (PEA), which contribute desirable rose-like aromas to fermented beverages . Studies have demonstrated that different species of Saccharomyces (S. cerevisiae, S. kudriavzevii, and S. uvarum) contain ARO80 variants with functional differences that affect aromatic compound production, making it an important target for both fundamental yeast biology and applied fermentation research.

How can I validate the specificity of an ARO80 antibody?

To validate ARO80 antibody specificity, implement a multi-step approach beginning with Western blot analysis comparing wild-type yeast strains with ARO80 deletion mutants (such as the aro80Δ strain described in the literature) . A specific antibody should show a band at the expected molecular weight (~84 kDa) in wild-type samples but not in the deletion mutant. Additionally, perform immunoprecipitation followed by mass spectrometry to confirm the pulled-down protein is indeed ARO80. For further validation, use tagged versions of ARO80 (with HA or Myc tags as shown in the research) in parallel experiments with both tag-specific antibodies and your ARO80 antibody to confirm co-localization . Finally, conduct cross-reactivity tests against other zinc cluster transcription factors that share structural similarities to ensure the antibody does not recognize related proteins.

What controls should I include when using ARO80 antibody in chromatin immunoprecipitation (ChIP) experiments?

When performing ChIP experiments with ARO80 antibody, multiple controls are essential. First, include an input control (typically 5% of starting material) as demonstrated in protein interaction studies with ARO80 . Second, use an IgG negative control from the same species as your ARO80 antibody to assess non-specific binding. Third, incorporate a positive control by amplifying known ARO80 binding sites in the promoters of ARO9 and ARO10 genes, which are well-established targets . Fourth, use an ARO80 deletion strain as a biological negative control. Fifth, perform ChIP with cells grown both with and without phenylalanine as this amino acid induces ARO80 binding activity, providing a functional control. Finally, consider including a strain expressing tagged ARO80 (HA-ARO80 or Myc-ARO80) and performing parallel ChIP with both tag-specific antibody and ARO80 antibody to validate consistent enrichment patterns at target promoters.

What are the optimal fixation conditions for immunolocalization of ARO80 in yeast cells?

For optimal immunolocalization of ARO80 in yeast cells, a balanced fixation approach is required that preserves protein antigenicity while allowing antibody access. Begin with a 3-4% formaldehyde fixation for 15-30 minutes at room temperature, as excessive fixation can mask epitopes. For cell wall digestion, use zymolyase (100T at 1mg/ml) in sorbitol buffer for 30-45 minutes at 30°C. When permeabilizing, use a gentle detergent like 0.1% Triton X-100 rather than harsher detergents that might denature the protein. Because ARO80 is a transcription factor that shuttles between cytoplasm and nucleus depending on the presence of aromatic amino acids, differential fixation and permeabilization may be required to capture different cellular states. Compare results from cells grown with ammonium sulfate versus phenylalanine as nitrogen sources, as ARO80 activity differs significantly between these conditions . Include appropriate controls with the ARO80 deletion strain and consider counter-staining with DAPI to confirm nuclear localization when ARO80 is active.

How can I use ARO80 antibody to investigate protein-protein interactions in the Ehrlich pathway regulation?

To investigate protein-protein interactions involving ARO80, employ a multi-technique approach centered on co-immunoprecipitation (Co-IP) with the ARO80 antibody. Based on recent findings, ARO80 interacts with other transcription factors including Cat8, Gat1, and Gln3 . For Co-IP experiments, extract total protein from yeast cultures grown under both inducing (phenylalanine-containing) and non-inducing conditions. Perform reciprocal Co-IPs using antibodies against both ARO80 and suspected interaction partners. For verification of results, consider using strains with differentially tagged proteins (e.g., ARO80-HA and potential partner-Myc) as demonstrated in the literature . Follow with Western blotting using appropriate antibodies to detect co-precipitated proteins.

For more detailed interaction analysis, combine this approach with chromatin immunoprecipitation sequencing (ChIP-seq) to map genome-wide binding sites and identify regions where ARO80 co-localizes with other transcription factors. Proximity ligation assays (PLA) can provide additional in situ evidence of protein interactions within the cellular context. Finally, validate functional relevance of identified interactions through genetic approaches, creating strains with mutations in the interaction domains and measuring effects on target gene expression (ARO9, ARO10) and aromatic compound production.

What methodological approaches can resolve contradictory data when using ARO80 antibody across different yeast species?

When faced with contradictory data using ARO80 antibody across different Saccharomyces species, a systematic troubleshooting approach is essential. First, evaluate epitope conservation by aligning ARO80 protein sequences from the species in question (S. cerevisiae, S. kudriavzevii, and S. uvarum). The research highlights several amino acid differences between these species' ARO80 proteins that could affect antibody recognition, particularly in the DNA-binding domain and middle homology region .

Create a comparative validation panel by expressing each species' ARO80 in an S. cerevisiae aro80Δ background (similar to the ST44-Sc, ST44-Sk, and ST44-Su strains described in the literature) . Test the antibody against all variants in parallel Western blots. If species-specific differences in antibody affinity are detected, consider developing a pan-specific antibody targeting highly conserved regions of ARO80, or use epitope tagging strategies with a common tag across all species.

For experiments requiring cross-species comparisons, implement a dual-detection system using both the ARO80 antibody and a species-neutral detection method such as a universal tag or mass spectrometry-based approaches. Finally, when reporting results, clearly specify which species' ARO80 was being detected and under what conditions to prevent misinterpretation of data.

How can I use ARO80 antibody to track conformational changes in response to aromatic amino acid induction?

Tracking ARO80 conformational changes in response to aromatic amino acid induction requires sophisticated antibody-based techniques. Develop or acquire conformation-specific antibodies that recognize distinct structural states of ARO80—one recognizing the inactive form and another recognizing the activated form that occurs after phenylalanine binding. Perform limited proteolysis experiments in conjunction with Western blotting to identify protease-sensitive sites that differ between the induced and uninduced states.

Combine this with hydrogen-deuterium exchange mass spectrometry (HDX-MS) where you first immunoprecipitate ARO80 using your antibody, then perform HDX-MS analysis to identify regions with altered solvent accessibility between different conditions. Time-course experiments are particularly valuable, as the research indicates that ARO9 and ARO10 expression peaks approximately 10 hours after phenylalanine induction before returning to baseline levels by 24 hours .

For in vivo tracking, consider using split-fluorescent protein complementation assays where fragments are attached to different domains of ARO80, allowing visualization of conformational changes through altered fluorescent signal patterns. When designing these experiments, pay special attention to the middle region between the DNA-binding domain and activation domain, as this contains amino acid changes that may be responsible for the functional differences between species variants .

What experimental approach should I use to measure ARO80 binding to UAS elements with antibody-based techniques?

To measure ARO80 binding to its UAS elements, implement a comprehensive ChIP-based experimental design. Begin with standard ChIP followed by qPCR targeting known UAS ARO elements in the promoters of ARO9 and ARO10. The literature indicates that ARO80 is constitutively bound to UAS ARO elements regardless of nitrogen source, but its transcriptional activity changes in response to aromatic amino acids . Therefore, perform ChIP experiments under both inducing (phenylalanine) and non-inducing (ammonium sulfate) conditions to distinguish between binding and activation.

For genome-wide binding profiles, scale up to ChIP-seq to identify all potential binding sites. Complement ChIP experiments with electrophoretic mobility shift assays (EMSA) using recombinant or immunopurified ARO80 and labeled oligonucleotides containing UAS ARO sequences. To correlate binding with functional outcomes, combine ChIP data with expression analysis of target genes through RT-qPCR or RNA-seq.

The experimental design should include multiple time points (particularly at 10, 24, and 30 hours post-induction) as the research demonstrates temporal differences in ARO9 and ARO10 expression patterns :

How should I optimize fixation and extraction conditions when working with ARO80 in different yeast growth phases?

For protein extraction in ChIP experiments, use mechanical disruption with glass beads for consistent results across growth phases. When performing Co-IP experiments, avoid harsh detergents that might disrupt protein-protein interactions, particularly when investigating ARO80's interactions with partners like Cat8, Gat1, and Gln3 . During the entire process, maintain samples at 4°C to prevent protein degradation.

Design a systematic optimization matrix testing different fixation times (10, 15, 20, 25 minutes), formaldehyde concentrations (0.8%, 1%, 1.2%), and extraction buffers (varying salt and detergent concentrations) for each growth phase. Evaluate extraction efficiency using Western blots with your ARO80 antibody, and fixation quality by chromatin shearing patterns and ChIP efficiency at known target sites (ARO9/ARO10 promoters).

What strategies can effectively differentiate between ARO80 and other zinc cluster transcription factors when using antibodies?

Differentiating between ARO80 and other zinc cluster transcription factors requires a multi-layered strategy. First, perform extensive computational analysis to identify unique epitopes in ARO80 that are absent in related transcription factors. Target these regions when generating or selecting antibodies. The research indicates that while the DNA-binding domain may be conserved among zinc cluster proteins, the middle region between positions 370-412 and other areas show significant variation .

Validate antibody specificity using a panel of yeast strains with individual deletions of various zinc cluster transcription factors. For critical experiments, consider using epitope-tagged versions of ARO80 (ARO80-HA or ARO80-Myc) as demonstrated in the research , allowing for parallel detection with both ARO80-specific and tag-specific antibodies.

Implement immunodepletion experiments where you first deplete samples of ARO80 using immobilized validated antibodies, then probe the depleted samples with your test antibody—any remaining signal would indicate cross-reactivity. For mass spectrometry-based approaches, design targeted assays that monitor peptides unique to ARO80. When reporting results, always include specificity controls and clearly state which validation steps were performed to ensure reproducibility and reliability of findings.

How do I interpret ChIP-seq data for ARO80 in the context of its interaction with other transcription factors?

When interpreting ChIP-seq data for ARO80, begin by identifying primary binding sites and correlating them with known ARO80 targets (ARO9, ARO10) as baseline validation. Next, perform motif analysis to confirm enrichment of the UAS ARO consensus sequence and potentially discover variant motifs. Because ARO80 interacts with other transcription factors including Cat8, Gat1, and Gln3 , look for co-occurrence of their binding motifs near ARO80 peaks.

Integrate your ARO80 ChIP-seq data with existing datasets for these interaction partners to identify regions of overlap versus distinct binding. Perform differential binding analysis between conditions (with/without phenylalanine) and time points (especially 10h vs. 24h post-induction) to capture the dynamic nature of ARO80 binding . For genomic regions where multiple transcription factors bind, conduct network analysis to predict cooperative or competitive relationships.

When analyzing binding near ARO9 and ARO10, consider the functional consequences by correlating binding patterns with expression data. The research shows that different ARO80 alleles result in varying expression levels of these genes, particularly with a two-fold higher expression in S. kudriavzevii and S. uvarum ARO80 variants compared to S. cerevisiae at the 10-hour timepoint . This differential expression correlates with increased production of aromatic compounds:

How can I use quantitative immunoblotting with ARO80 antibody to assess transcription factor levels across different experimental conditions?

For quantitative immunoblotting of ARO80, establish a robust protocol that ensures linear signal response across the expected concentration range. Begin by creating a standard curve using recombinant ARO80 or cellular extracts with known amounts of ARO80. Select a housekeeping protein that remains stable across your experimental conditions for normalization—the research used ACT1 and 18S rRNA for related gene expression studies .

When comparing ARO80 levels across different nitrogen sources or time points, extract proteins using a consistent method that maintains protein integrity. Include phosphatase inhibitors in your extraction buffer, as many transcription factors are regulated by phosphorylation. For detection, use fluorescent secondary antibodies rather than chemiluminescence for more accurate quantification.

Analyze immunoblot data using image analysis software that allows for background subtraction and normalization. Present data as relative ARO80 levels normalized to your housekeeping protein, and perform statistical analysis to determine significance of any observed differences. When comparing ARO80 levels with functional outcomes like phenylethanol production, consider using correlation analysis to establish relationships between protein levels and metabolite production.

Based on the research findings, you might expect to see differences in ARO80 protein levels or modifications between induced (phenylalanine) and non-induced (ammonium sulfate) conditions, particularly around the 10-hour timepoint when target gene expression peaks .

What statistical approaches are most appropriate for analyzing ARO80 binding data from ChIP-qPCR experiments?

For ChIP-qPCR data analysis of ARO80 binding, implement a multi-step statistical framework. Begin with normalization of ChIP signal to input control for each target region, typically calculated as percent input or fold enrichment over background. For comparing ARO80 binding across different conditions (e.g., different nitrogen sources or time points), use paired statistical tests that account for experimental variability.

When analyzing binding to multiple regions (e.g., different UAS ARO elements), apply ANOVA with post-hoc tests to identify statistically significant differences between binding sites. For time-course experiments, consider repeated measures ANOVA or mixed-effects models to account for the non-independence of measurements across time points.

Based on the literature, you would expect differential binding or activation patterns that correlate with the expression profiles of ARO9 and ARO10, with potentially higher activation (though not necessarily binding) when cells are grown with phenylalanine versus ammonium sulfate . When analyzing binding data for different ARO80 variants (Sc, Sk, Su), take into account the amino acid differences that might affect antibody recognition and normalize accordingly.

For correlating binding with functional outcomes, use regression analysis to establish relationships between ARO80 binding intensity and target gene expression levels or metabolite production. The research indicates that S. kudriavzevii and S. uvarum ARO80 variants lead to approximately two-fold higher expression of target genes at the 10-hour timepoint compared to S. cerevisiae ARO80 , so your statistical approach should be sensitive enough to detect these magnitudes of difference.

What are the most common causes of false positive and false negative results when using ARO80 antibody, and how can they be addressed?

False positive and false negative results with ARO80 antibody can stem from multiple sources. For false positives, cross-reactivity with other zinc cluster transcription factors is a primary concern due to structural similarities in their DNA-binding domains. To address this, implement stringent blocking conditions (5% BSA or milk protein) and validate specificity using ARO80 deletion strains as negative controls. Non-specific binding to protein A/G can also cause false positives in immunoprecipitation experiments; counter this by pre-clearing lysates with beads alone before adding the ARO80 antibody.

For false negatives, epitope masking due to protein-protein interactions or conformational changes is a common issue, particularly relevant for ARO80 which changes its transcriptional activity upon aromatic amino acid induction . Try multiple antibodies targeting different regions of ARO80 or use denaturing conditions when appropriate. Insufficient extraction from the nucleus where ARO80 functions can also cause false negatives; ensure your protocol includes proper nuclear lysis steps.

Batch-to-batch antibody variation can affect both types of errors; maintain consistency by using the same lot when possible or thoroughly validating new lots against previous ones. For Western blotting specifically, optimize transfer conditions for ARO80's molecular weight (~84 kDa) as incomplete transfer of higher molecular weight proteins can lead to false negatives. Finally, remember that ARO80 activity changes temporally after induction , so sampling at inappropriate time points might miss peak activity, creating apparent false negatives.

How can I optimize immunoprecipitation protocols for ARO80 when studying its interaction with the Ehrlich pathway enzymes?

Optimizing immunoprecipitation of ARO80 for studying its interactions with Ehrlich pathway enzymes requires careful attention to extraction and binding conditions. Begin with a gentle cell lysis procedure using glass bead disruption in a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 0.1% NP-40, with protease and phosphatase inhibitors. For crosslinking approaches, use a lower formaldehyde concentration (0.5-0.8%) to preserve protein-protein interactions without over-fixation.

The research identifies ARO80 as regulating key Ehrlich pathway genes (ARO9, ARO10) , and interacting with other transcription factors like Cat8 . To preserve these interactions, avoid harsh detergents and high salt concentrations that might disrupt weak or transient interactions. Consider using a two-step immunoprecipitation approach: first pull down ARO80 using your antibody, then perform a second immunoprecipitation targeting the enzyme of interest.

Include appropriate controls: an input sample (5% of starting material), an IgG negative control, and immunoprecipitation from an ARO80 deletion strain as demonstrated in the research . For detecting co-immunoprecipitated proteins, use antibodies specific to the Ehrlich pathway enzymes (Aro9p, Aro10p, Bat2p, Adh2p) or consider using strains expressing epitope-tagged versions of these enzymes for consistent detection.

To enhance specificity, implement stringent washing conditions (increasing salt concentration in sequential washes) while maintaining sufficient sensitivity. Finally, validate any detected interactions using reciprocal immunoprecipitation and orthogonal methods such as yeast two-hybrid or bimolecular fluorescence complementation.

What approaches can resolve antibody detection issues when ARO80 undergoes post-translational modifications during activation?

Resolving detection issues when ARO80 undergoes post-translational modifications requires a multi-faceted approach. First, generate or acquire phospho-specific antibodies that recognize ARO80 in its activated state, as transcription factors often undergo phosphorylation upon activation. Use lambda phosphatase treatment of parallel samples to confirm phosphorylation-dependent recognition.

Employ multiple antibodies targeting different epitopes across the ARO80 protein to ensure detection regardless of modification state. The research suggests that the middle region between the DNA-binding domain and activation domain may be important for ARO80 regulation , making this area a potential site for post-translational modifications that could affect antibody recognition.

Implement phos-tag gel electrophoresis before Western blotting to separate phosphorylated from non-phosphorylated forms of ARO80, allowing visualization of the modification landscape. For comprehensive detection, consider mass spectrometry-based approaches following immunoprecipitation to identify all modifications and their sites.

When examining ARO80 activation dynamics, design time-course experiments that capture the protein state at multiple points after induction with phenylalanine. The research indicates peak activity around 10 hours post-induction with differences between ARO80 variants , suggesting this timeframe is critical for observing relevant modifications. Finally, compare modification patterns between different ARO80 alleles (Sc, Sk, Su) to correlate post-translational modifications with the functional differences observed in aromatic compound production and target gene expression.